NYSE:ATH

Athene Stock Forecast, Price & News

$64.83
+0.45 (+0.70 %)
(As of 06/25/2021 09:38 AM ET)
Add
Compare
Today's Range
$64.74
$66.00
50-Day Range
$55.35
$64.38
52-Week Range
$29.17
$64.72
Volume877 shs
Average Volume1.19 million shs
Market Capitalization$12.43 billion
P/E Ratio4.10
Dividend YieldN/A
Beta1.68
30 days | 90 days | 365 days | Advanced Chart
Receive ATH News and Ratings via Email

Sign-up to receive the latest news and ratings for Athene and its competitors with MarketBeat's FREE daily newsletter.


Athene logo

About Athene

Athene Holding Ltd., a retirement services company, issues, reinsures, and acquires retirement savings products for individuals and institutions in the United States and Bermuda. The company provides annuity retirement solutions to its policyholders; and reinsures multi-year guaranteed annuities, fixed indexed annuities, traditional one-year guarantee fixed deferred annuities, immediate annuities, and institutional products. It also offers funding agreements and pension risk transfer transactions, as well as group annuities. The company was incorporated in 2008 and is headquartered in Hamilton, Bermuda.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.69 out of 5 stars

Finance Sector

499th out of 1,976 stocks

Life Insurance Industry

12th out of 41 stocks

Analyst Opinion: 2.2Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Athene (NYSE:ATH) Frequently Asked Questions

Is Athene a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Athene stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATH, but not buy additional shares or sell existing shares.
View analyst ratings for Athene
or view top-rated stocks.

What stocks does MarketBeat like better than Athene?

Wall Street analysts have given Athene a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Athene wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Athene?

Athene saw a decline in short interest during the month of May. As of May 28th, there was short interest totaling 7,000,000 shares, a decline of 20.4% from the May 13th total of 8,790,000 shares. Based on an average trading volume of 1,710,000 shares, the days-to-cover ratio is currently 4.1 days. Approximately 5.3% of the company's shares are sold short.
View Athene's Short Interest
.

When is Athene's next earnings date?

Athene is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Athene
.

How were Athene's earnings last quarter?

Athene Holding Ltd. (NYSE:ATH) announced its quarterly earnings data on Friday, May, 7th. The insurance provider reported $3.80 EPS for the quarter, beating the consensus estimate of $2.15 by $1.65. The insurance provider had revenue of $1.70 billion for the quarter, compared to analysts' expectations of $1.61 billion. Athene had a trailing twelve-month return on equity of 12.19% and a net margin of 15.47%. The company's revenue for the quarter was up 128.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.36) EPS.
View Athene's earnings history
.

How has Athene's stock price been impacted by Coronavirus (COVID-19)?

Athene's stock was trading at $31.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ATH shares have increased by 106.6% and is now trading at $64.38.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ATH?

13 brokerages have issued 12-month target prices for Athene's shares. Their forecasts range from $50.00 to $83.00. On average, they expect Athene's share price to reach $60.92 in the next year. This suggests that the stock has a possible downside of 5.4%.
View analysts' price targets for Athene
or view top-rated stocks among Wall Street analysts.

Who are Athene's key executives?

Athene's management team includes the following people:
  • Mr. James Richard Belardi, Co-Founder, Chairman, CEO & Chief Investment Officer (Age 64, Pay $952.2k)
  • Mr. William James Wheeler, Pres (Age 59, Pay $3.05M)
  • Mr. Martin Philip Klein, Exec. VP & CFO (Age 61, Pay $2.11M)
  • Mr. John Leonard Golden J.D., Exec. VP & Gen. Counsel (Age 41, Pay $1.18M)
  • Mr. Grant Kvalheim, Exec. VP and CEO & Pres of Athene USA (Age 64, Pay $2.51M)
  • Ms. Sarah Jean VanBeck CPA, Sr. VP, Corp. Controller & Principal Accounting Officer (Age 57)
  • Mr. Randall William Epright, Exec. VP & Chief Information Officer (Age 58)
  • Mr. Noah Gunn, Head of Investor Relations
  • Ms. Megan A. Claypool, SVP & Chief Compliance Officer
  • Ms. Karen Lynn, Sr. VP of Corp. Communications

Who are some of Athene's key competitors?

What other stocks do shareholders of Athene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include DocuSign (DOCU), AT&T (T), Alibaba Group (BABA), Intel (INTC), Applied Materials (AMAT), JD.com (JD), Okta (OKTA), Visa (V), Slack Technologies (WORK) and AbbVie (ABBV).

When did Athene IPO?

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

What is Athene's stock symbol?

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Who are Athene's major shareholders?

Athene's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.45%), Samlyn Capital LLC (2.79%), Dimensional Fund Advisors LP (1.96%), Goldman Sachs Group Inc. (1.69%), Lakewood Capital Management LP (1.31%) and Massachusetts Financial Services Co. MA (1.09%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, H Carl Mccall, James Richard Belardi, John Leonard Golden, Lawrence Ruisi, Marc A Beilinson, Martin P Klein and Robert L Borden.
View institutional ownership trends for Athene
.

Which major investors are selling Athene stock?

ATH stock was sold by a variety of institutional investors in the last quarter, including Samlyn Capital LLC, Arrowstreet Capital Limited Partnership, HRT Financial LP, Cubist Systematic Strategies LLC, State of Wisconsin Investment Board, Vaughan Nelson Investment Management L.P., Picton Mahoney Asset Management, and Prudential Financial Inc.. Company insiders that have sold Athene company stock in the last year include H Carl Mccall, John Leonard Golden, Martin P Klein, and Robert L Borden.
View insider buying and selling activity for Athene
or view top insider-selling stocks.

Which major investors are buying Athene stock?

ATH stock was acquired by a variety of institutional investors in the last quarter, including Pentwater Capital Management LP, Versor Investments LP, Man Group plc, Bank of Nova Scotia, Lakewood Capital Management LP, Morgan Stanley, Neuberger Berman Group LLC, and BNP Paribas Arbitrage SA. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene
or or view top insider-buying stocks.

How do I buy shares of Athene?

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Athene's stock price today?

One share of ATH stock can currently be purchased for approximately $64.38.

How much money does Athene make?

Athene has a market capitalization of $12.34 billion and generates $14.76 billion in revenue each year. The insurance provider earns $1.54 billion in net income (profit) each year or $6.42 on an earnings per share basis.

How many employees does Athene have?

Athene employs 1,350 workers across the globe.

What is Athene's official website?

The official website for Athene is www.athene.com.

Where are Athene's headquarters?

Athene is headquartered at 96 Pitts Bay Road, Pembroke D0, HM08.

How can I contact Athene?

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at (441) 279-8400 or via email at [email protected]


This page was last updated on 6/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.